Trends in First-Line Glaucoma Treatment from 2013 to 2024: A Multi-institutional and Multinational Cohort Study
Medication therapy accounted for most first-line treatment in both OAG and ACG between 2013 and 2024. Over time, treatment patterns shifted toward greater use of surgery in OAG and increased reliance on medication in ACG. These trends highlight the need for future studies to evaluate long-term outcomes and inform subtype-specific glaucoma care.
Authors
- Shih‐Chieh Shao (ORCID: https://orcid.org/0000-0003-4867-6686)
- Lan-Hsin Chuang
- Daniel Hsiang-Te Tsai
- Edward Chia-Cheng Lai
- Yuan-Hsi Chan
- Chi-Chun Lai
Institutions
- Chang Gung University (TW)
- Keelung Chang Gung Memorial Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Ophthalmology and Therapy
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1007/s40123-026-01327-y
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chang Gung Medical Foundation
- National Health Research Institutes
- National Science and Technology Council